Oncode Institute - Our stories

First Start-up Oncode Institute launched

Oncode Investigator, Alexander van Oudenaarden, is one of the pioneers in the field of single-cell sequencing. From his lab at the Hubrecht Institute the company Single Cell Discoveries was recently launched with the help of the valorization team of Oncode.

Hidde Boersma

Fundamental Science: an uncertain endeavour into uncharted territory

Oncode invests in curiosity driven research. We asked Oncode Investigator Madelon Maurice and General Director Ton Rijnders to explain why.

Hidde Boersma

Open call for Oncode Investigator applications

Oncode Institute has opened a call for applications for our Oncode Recruitment Programme. Up to eleven scientists will be awarded base-funding for the remaining duration of the first phase of Oncode.

TaleSliedrecht

On hair balls, ink pads, and folds

Neatly rolled up in a cell nucleus of only a hundredth of a millimetre in size, our genome consists of approximately two metres of DNA spread over 46 chromosomes. Three Oncode Investigators explain why they are fascinated by the spatial organization of this tiny ball of thread.

Lindavan den Berg

Geert Kops appointed as Scientific Director

Starting June 2018, professor Geert Kops will be Chief Scientific Officer of Oncode. In that role he is responsible for the overall research strategy and its proper execution.

AlexanderDuyndam

H.M. Queen Máxima officially launches Oncode Institute

With so much excellent cancer research already being done in the Netherlands, what value can a new organization add? That question was answered today in the presence of Her Majesty Queen Máxima, who officially opened Oncode Institute with an elegant gesture.

DesireeHoving

An open letter to patients

On the occasion of the launch of Oncode Institute, we, the institute’s founding scientists, wish to say a few words to you.

RenéBernards

The benefits of unrestricted grants

What if researchers were given money along with the freedom to work as they wished, without the red tape?

Hidde Boersma

Successful partnerships

What do haploid cells, the common cold and certain congenital illnesses have in common? Each one is the focus of a small biotech company started by fundamental researcher Thijn Brummelkamp.

Hidde Boersma